{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T01:36:42Z","timestamp":1787017002190,"version":"build-2736575974"},"reference-count":8,"publisher":"BMJ","issue":"7585","license":[{"start":{"date-parts":[[2007,1,18]],"date-time":"2007-01-18T00:00:00Z","timestamp":1169078400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.bmj.com\/company\/legal-information\/terms-conditions\/legal-information\/tdm-licencepolicy"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMJ"],"published-print":{"date-parts":[[2007,1,20]]},"DOI":"10.1136\/bmj.39048.540394.be","type":"journal-article","created":{"date-parts":[[2007,1,18]],"date-time":"2007-01-18T18:28:38Z","timestamp":1169144918000},"page":"154-154","source":"Crossref","is-referenced-by-count":24,"title":["Don't use minocycline as first line oral antibiotic in acne"],"prefix":"10.1136","volume":"334","author":[{"given":"Paul","family":"McManus","sequence":"first","affiliation":[{"name":"Drug and Therapeutics Bulletin, BMA House, London WC1H 9JR"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ike","family":"Iheanacho","sequence":"additional","affiliation":[{"name":"Drug and Therapeutics Bulletin, BMA House, London WC1H 9JR"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2007,1,18]]},"reference":[{"key":"2025111415351071000_334.7585.154.1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2001.04346.x"},{"key":"2025111415351071000_334.7585.154.2","doi-asserted-by":"crossref","unstructured":"Garner SE, Eady EA, Popescu C, Newton J, Li WA. Minocycline for acne vulgaris: efficacy and safety. Cochrane Database Syst Rev 2003;(1):CD002086.","DOI":"10.1002\/14651858.CD002086"},{"key":"2025111415351071000_334.7585.154.3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)17591-0"},{"key":"2025111415351071000_334.7585.154.4","first-page":"130","volume":"13","year":"2003","journal-title":"Eur J Dermatol"},{"key":"2025111415351071000_334.7585.154.5","doi-asserted-by":"publisher","DOI":"10.1159\/000049398"},{"key":"2025111415351071000_334.7585.154.6","unstructured":"Minocin MR Summary of product characteristics."},{"key":"2025111415351071000_334.7585.154.7","doi-asserted-by":"publisher","DOI":"10.1136\/dtb.2006.44860"},{"key":"2025111415351071000_334.7585.154.8","unstructured":"British Medical Association, Royal Pharmaceutical Society of Great Britain. British national formulary. 52nd ed. London: BMA, RPS, 2006."}],"container-title":["BMJ"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/data.bmj.org\/tdm\/10.1136\/bmj.39048.540394.BE","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmj.39048.540394.BE","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T23:35:35Z","timestamp":1763163335000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.bmj.com\/lookup\/doi\/10.1136\/bmj.39048.540394.BE"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1,18]]},"references-count":8,"journal-issue":{"issue":"7585","published-online":{"date-parts":[[2007,1,18]]},"published-print":{"date-parts":[[2007,1,20]]}},"alternative-id":["10.1136\/bmj.39048.540394.BE"],"URL":"https:\/\/doi.org\/10.1136\/bmj.39048.540394.be","relation":{},"ISSN":["0959-8138","1756-1833"],"issn-type":[{"value":"0959-8138","type":"print"},{"value":"1756-1833","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,1,18]]}}}